Skip to main content
Premium Trial:

Request an Annual Quote

Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests

NEW YORK – Diagnostic firm SpeeDx announced Tuesday a partnership with Roche to expand global access to the firm's infectious disease and antibiotic resistance tests and technology.

Under the non-exclusive agreement, Roche will have access to SpeeDx's existing tests and technology, expanding patient access to diagnostic products, including new ones, for the management of antibiotic resistance in sexually transmitted infections, the firm said in a statement.

Financial and other terms of the deal were not disclosed. 

Sydney, Australia-based SpeeDx currently offers multiplex qPCR tests for gonorrhea and Mycoplasma genitalium, which the firm noted are listed by the US Centers for Disease Control and Prevention as key threats because of the rise of antibiotic resistance and limited treatment options. The tests help physicians choose targeted therapies for patients based on the resistance status of their infections, the company said.

Last year, SpeeDx received CE-IVD marking for its M. gen test on the Cepheid FleXible cartridge detecting M. gen and five markers of resistance to the macrolide antibiotic azithromycin. Earlier this year, the firm partnered with Laboratory Corporation of America to codevelop diagnostic tests for women's health and infectious disease indications. 

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.